Company intelligence / Profile preview

Peterson Companies

Fairfax, Virginia, United Stateskastle.com ↗

Ownership: Private
Development stage: Other

Overview

Peterson Companies is a diversified private investment firm best known for real estate but also active as an investor in life sciences and healthcare ventures. It was a majority shareholder of Propella Therapeutics, which developed PRL-02 for prostate cancer before being acquired by Astellas Pharma in 2023 for $175 million. The firm's biotech venture arm Vizuri Health Sciences LLC focuses on over-the-counter drug products and has inked several deals in that space.

Modalities: Small molecule drugsPlatform technologies
Industry: Investors

Partnerships

Invested in Propella Therapeutics (acquired by Astellas Pharma)Multiple licensing/deal partnerships through Vizuri Health Sciences LLC

Beyond the preview

Go deeper on Peterson Companies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peterson Companies.

Explore the full profile